MANAGEMENT AND ADVISORS

 MANAGEMENT

 

Dr Vasilis Paspaliaris, BSc(Hons), PhD, MD
Chairman and Chief Executive Officer

Mr Peter Milonas, B(SSc), CEP(APMA)
Vice President and Chief Operating Officer

Dr George Kolios, MD, PhD
Chief Scientific and Research Officer

Mr David Strawn, JD
Director of Legal and Compliance

 

MEDICAL AND SCIENTIFIC ADVISORY BOARD

 

Dr Nick Lolatgis, MBBS, FRANZCOG, FRCOG
Obstetrician, Gynecologist, Fertility Specialist

Dr Joseph Purita, MD
Orthopedic Surgeon

Dr Ashley Granot, MBBS, FFMACCS, FACO, FACNEM, ABAARM, MAS5M
Cosmetic Surgeon

Dr Harry Reich, MD, FACOG, FACS
Gynecologist

Professor Demosthenes Bouros, MD, PhD, FCCP
Pulmonologist

Professor Fred Fändrich, MD, PhD
Transplant Surgeon, Immunologist

Dr Christian Paulos, MD

Dr Christian Paulos, MD

Regenerative Medicine Educator

Dr Christian Paulos is currently Chief Executive Officer for Stem Cell Centers of America, a Florida, U.S. based Regenerative Medicine company. Dr Paulos is also the co-founder, secretary and treasurer of the American Academy and Board of Regenerative Medicine. In addition, he serves as Chief Executive Officer of Regenovation Biotech LLC, a biomedical device company with Regenerative Medicine product lines. A native of Germany, Dr Paulos spent his career with the U.S. Department of Defense, both as a combat aviator and aerospace medicine physician. During that time, he flew combat missions, performed aerospace medicine research, and served as a field grade officer.

Following his military career, Dr Paulos built Medical Media Images, a company specialising in the color conversion of radiologic images. He developed a proprietary technique which produced the world’s first colour X-Ray, CT, and MRI images. Dr Paulos entered the Regenerative Medicine as Chief Medical Officer of StemMD. Subsequently, he became cofounder of Stem Cell Centers of America and the American Academy and Board of Regenerative Medicine. His broad interests encompass medical device development, regulatory affairs, business development, novel cell-based therapies, as well as advancement in the practice and education in Regenerative Medicine.